Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:58:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers for a clinical trial related to Bullous Pemphigoid and has revised the version number of the document. Additionally, the previous detailed description of the study's purpose and criteria has been removed.
    Difference
    17%
    Check dated 2025-04-16T02:20:09.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-09T00:39:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 6, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T19:06:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:19:23.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage has updated its information regarding data sharing policies for Regeneron-sponsored clinical trials, including new criteria for accessing data and changes in the status of services and products. Additionally, several dates have been revised or removed, indicating a shift in the timeline for updates and availability.
    Difference
    9%
    Check dated 2025-02-10T09:40:09.000Z thumbnail image

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.